Mercaptopurine + Ustekinumab Hmny Interaction

Moderateinteraction on record

Description

Used concomitantly in approximately 30% of Crohn's disease and ulcerative colitis subjects; did not appear to influence overall safety or efficacy.

Source: NLP:ustekinumab-hmny

Related drug profiles

All Mercaptopurine interactions →All Ustekinumab Hmny interactions →
Share this page:XFacebookWhatsAppReddit